Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA
Vanda (VNDA) Financial Statements
315 Followers
Vanda Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 46.06M | $ 62.50M | $ 64.48M | $ 65.32M | $ 64.39M |
| Gross Profit | $ 42.56M | $ 62.50M | $ 64.48M | $ 59.00M | $ 58.33M |
| EBIT | $ 2.59M | $ 5.53M | $ 9.68M | $ 3.91M | $ 3.46M |
| EBITDA | $ 3.22M | $ 5.93M | - | $ 4.59M | $ 4.15M |
| Net Income Common Stockholders | $ 1.52M | $ 3.21M | $ 6.95M | $ 3.27M | $ 2.57M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 489.35M | $ 354.17M | $ 135.03M | $ 454.79M | $ 440.86M |
| Total Assets | $ 641.68M | $ 644.53M | $ 302.42M | $ 621.79M | $ 609.10M |
| Total Debt | $ 7.94M | $ 155.71M | $ 340.64M | $ 11.10M | $ 11.53M |
| Net Debt | $ -481.41M | $ -198.46M | $ 205.61M | $ -443.69M | $ -429.33M |
| Total Liabilities | $ 101.78M | $ 108.79M | $ 966.08M | $ 106.13M | $ 100.55M |
| Stockholders Equity | $ 539.90M | $ 535.74M | $ 527.20M | $ 515.66M | $ 508.55M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -13.25M | $ 31.77M | $ 9.17M | $ 12.69M | $ 5.49M |
| Operating Cash Flow | $ -13.20M | $ 31.82M | $ 9.44M | $ 12.84M | $ 5.68M |
| Investing Cash Flow | $ -190.89M | $ 187.29M | $ 75.43M | $ -21.78M | $ -14.59M |
| Financing Cash Flow | - | - | $ 600.00K | $ 4.00K | $ 125.00K |